抗体-药物结合物 (ADC):当前和未来的生物制药
Ruili Wang1, Baohui Hu1, Ziyu Pan1
1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, China.
Journal of hematology & oncology
|April 30, 2025
概括
抗体-药物合物 (ADC) 通过将抗体与细胞毒药物结合,提供向癌症治疗. 本综述探讨了ADC设计,已批准的疗法以及改善安全性和疗效的未来方向.
科学领域:
- 生物制药产品 生物制药产品
- 在瘤学瘤学.
- 药物运输 药物运输 药物运输
背景情况:
- 抗体-药物结合剂 (ADCs) 将单克隆抗体与细胞毒剂结合起来,用于向癌症治疗.
- 与传统化疗相比,ADCs提供了更好的疗效和降低了毒性.
- 目前已批准15种ADC,正在对自身免疫性疾病和感染进行研究.
研究的目的:
- 提供ADC的全面概述,包括它们的结构部件 (抗体,链接器,有效载荷).
- 评估15种已批准的抗癌药物在癌症治疗中的进展和挑战.
- 探索ADC发展的未来方向和持续挑战.
主要方法:
- 对ADC组件的结构和功能特征的审查.
- 在癌症治疗中对15种已批准的ADC进行系统评估.
- 对ADC发展当前挑战和未来前景的分析.
主要成果:
- ADCs使细胞毒剂的向输送成为可能,最大限度地减少了非向效应.
- 经批准的ADCs显示了更高的治疗效果,毒性更少.
- 关键的挑战包括抗体免疫性,链接器稳定性和有效载荷释放控制.
结论:
- ADCs代表了针对性癌症治疗的重大进步.
- 需要进一步优化,以应对安全和效率方面的挑战.
- 未来的研究旨在加强ADC设计,以更广泛的临床应用.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
8.3K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
7.4K
相关概念视频
Antibody Structure
57.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
57.5K
Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K
Antibody Actions
961
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
961
Phase II Conjugation Reactions: Overview
109
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
109
